Edition:
United Kingdom

People: Mithra Pharmaceuticals SA (MITRA.BR)

MITRA.BR on Brussels Stock Exchange

26.86EUR
22 Jul 2019
Change (% chg)

€-0.24 (-0.89%)
Prev Close
€27.10
Open
€27.30
Day's High
€27.30
Day's Low
€26.70
Volume
41,532
Avg. Vol
35,045
52-wk High
€36.95
52-wk Low
€18.12

Fornieri, Francois 

Mr. Francois Fornieri is Chief Executive Officer, Chief Business Development Officer, Executive Director - Representative of YIMA SPRL of Mithra Pharmaceuticals SA. Mr Fornieri has over 25 years of pharmaceutical experience with a strong focus on women’s health. He obtained a degree in Chemistry and is the founder and CEO of the Company. François previously worked for Bayer-Schering and was also a co-founder of Uteron Pharma, which was sold to Watson/Actavis (NYSE: ACT) early 2013. François has been elected the French speaking “2011 Manager of the year” by the Belgian business magazine Trends/Tendances.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --